10-13 Jan 2022 – H.C. Wainwright Bioconnect Conference

Small Pharma is participating in the H.C. Wainwright Bioconnect Conference which is being held Monday, January 10 to Wednesday, January 13, 2022.

H.C. Wainwright Bioconnect Conference (January 10-13, 2022)

Small Pharma will also participate in a fireside chat at the H.C. Wainwright Bioconnect Conference, which will be held virtually. The fireside chat will be available on-demand from January 10, 2022, at 7:00 a.m. ET.

Webcast Information:

Presenter: Peter Rands, Chief Executive Officer and Dr Carol Routledge, CSMO
Date:  January 10
Time:  On-Demand from 7:00 a.m. ET
Webcast Link:  Click here

Virtual Meeting Availability:

For institutional investors wishing to book a 1-on-1 meeting with the Company – please register directly with the organizer through H.C. Wainwright’s conference portal or through your institutional sales representative.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: